Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan
· Delayed Price · Currency is TWD 64.00
-0.50 (-0.78%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Medicine | 3.10B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicine Growth | 8.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dietary Supplement | 2.09B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dietary Supplement Growth | 7.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Active Pharmaceutical Ingredients | 1.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Active Pharmaceutical Ingredients Growth | 15.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 272.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -6.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 272.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -6.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Other | 1.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 154.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan | 5.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | 9.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 437.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 45.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 154.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vietnam | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vietnam Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Saudi Arabia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Saudi Arabia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Philippines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Philippines Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Singapore | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Singapore Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Thailand | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Thailand Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Egypt | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Egypt Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|